Navigation Links
Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions
Date:9/8/2011

b is a potent oral inhibitor of a number of pro-inflammatory enzymes collectively known as secretory phospholipase A2 (sPLA2). Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including ACS and acute chest syndrome, as well as chronic diseases, such as stable coronary artery disease (CAD). In Anthera's FRANCIS Phase 2 clinical study in ACS patients, treatment with varespladib improved independent markers of cardiovascular risk including C-reactive protein, IL-6, LDL-C and varespladib's target enzyme, sPLA2. Recent analysis of data from diabetic patients in the same Phase 2 study demonstrated treatment with varespladib was associated with early and statistically significant reductions in these prognostic inflammatory markers of cardiovascular risk. VISTA-16 is an event driven clinical study evaluating the use of varespladib methyl in combination with Lipitor (atorvastatin calcium) to reduce secondary Major Adverse Cardiovascular Events in patients who have recently experienced an Acute Coronary Syndrome. In February 2010, Anthera received a SPA from the U.S. FDA for the VISTA-16 Phase 3 study for the use of varespladib in treating high-risk ACS patients.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has three late stage clinical products: varespladib methyl (A-002), A-001 and blisibimod (A-623). Varespladib methyl (A-002) and A-001 are designed to inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA2). Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. Blisibimod targets elevated levels of B-lymphocyte stimulator (BAFF) whic
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
2. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
3. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
5. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
6. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
7. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
8. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
9. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
10. Anthera Announces Update Call Regarding Vial Problems
11. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 The North American ... and is estimated to reach $90.7 million by 2019, at ... Browse through the TOC of North America Dental Lasers Market ... help of various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... on this report.   Dental lasers are ...
(Date:5/22/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... the results of the Company,s 72-patient, placebo-controlled Phase ... for the treatment of dry eye patients using ... model.  The exploratory study was completed in late ... by the Company in a press release, identify ...
(Date:5/22/2015)... Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a ... its CGuard TM Embolic Prevention System reported positive results ... , at the EuroPCR conference on May 22, ... PARADIGM, an investigator-initiated P rospective evaluation of A ... I n symptomatic and increased-risk asymptomatic carotid artery stenosis, ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Chapter - Bay State Branch of the Juvenile Diabetes Research ... research worldwide and the largest charitable funder and advocate of ... Heroes Gala on Saturday, May 16, 2009 at the Boston ... DeSisto, President and Chief Executive Officer of Insulet Corporation, as ...
... Accelerates the Healing Process , in Damaged Tissue ... Today , a leading expert in the field ... demonstrating that glycerin helps to speed up the healing ... bruising and skin discoloration.In a double-blinded, placebo-controlled clinical study ...
Cached Medicine Technology:Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala 2Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala 3Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala 4Glycerin Proven to Improve Bruising and Swelling Caused By Trauma to Skin 2
(Date:5/22/2015)... Wimbledon Health Partners, the leading on-site ... and NCV testing , is proud to announce ... American National athlete, to the Wimbledon Athletics division. ... level of testing and information it provides to be ... trainers, this way they can focus on the task ...
(Date:5/22/2015)... 22, 2015 In an effort to ... Sons is offering to donate $5 dollars for every ... unit or water softening system. Customers have their needs ... Sons gets business; and the Special Olympics receives money. ... Olympics helps over 4.4 million athletes, and boasts a ...
(Date:5/22/2015)... Co founders Greenlee and James Chapko, DDS have ... to immediately deliver fully integrated dental implant services to their ... medical surgeon. , The Center, whose name is ... from placing dental implants. These 6 roadblocks can discourage ... surgical placement of dental implants into his or her practice. ...
(Date:5/22/2015)... Puritan Medical Products, a Maine ... diagnostic, environmental, and forensics industries celebrates 96 years ... the US. At a time when countless manufacturing ... Puritan remains committed to designing and manufacturing their ... facility. , Since 1919, Puritan has focused on ...
(Date:5/22/2015)... Javon Bea Mercy Health System : ... the highest quality emergency care services, especially by women ... Javon R. Bea, President and CEO of Mercy Health ... to care for and respond to what is most ... for this award, but are selected if they consistently ...
Breaking Medicine News(10 mins):Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2
... Web site,s c ontent is ... CHICAGO, July 15 In an emergency, immediate access to ... death. Personal health records (PHRs) often help ease the tension and ... encounters. To increase its PHR public outreach, the American Health Information ...
... , Goodman: Bill Contains All the Bad ... DALLAS, July 15 The Democrats, health care reform bill currently ... health plan that will undercut the private market and force as many ... forced into a Medicare-like plan, according to National Center for Policy Analysis ...
... , Dr. Thomas Bryant Brings Hill ... WASHINGTON, July 15 The National Coalition of Mental ... Bryant, MD, JD, as its first-ever Director of Government Relations. Dr. ... excited to join the staff of the National Coalition. The most ...
... HMSY ) today announced it will host a webcast and conference call at 9:00 am ET on ... which ended June 30. Financial results are scheduled for release before the market opens on Friday, ... William Lucia, CEO, Walter Hosp, CFO, ... 9:00 AM ET, , , HOW: Presentation: , ...
... , , American Society of ... s Water and Wastewater Infrastructure Systems , ... owe our health and much of our quality of life to the ... water and wastewater systems on which we rely. Despite the importance of ...
... , BETHESDA, Md., July 15 ... solutions, today announced the release of the PatientLife System(R) 3.5 (PLS ... focused on accelerating the discharge planning process and reducing average length ... , "We are excited about the new functionality of ...
Cached Medicine News:Health News:AHIMA Launches New Interactive myPHR.com Web Site 2Health News:AHIMA Launches New Interactive myPHR.com Web Site 3Health News:House Democrat's Health Care Reform Bill Is a 1,018-Page Nightmare 2Health News:National Coalition of Mental Health Consumer/Survivor Organizations Hires Director of Government Relations 2Health News:HMS Holdings Corp. Hosts Second Quarter 2009 Financial Teleconference and Presentation 2Health News:Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 2Health News:GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 2Health News:GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 3Health News:GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 4
... is the #1 Pipettor for sub-microliter ... and reliability. Continuously adjustable. Features lPLUS, ... Easy interchangeable ejector buttons to fit ... rapid pipet tip ejector with three ...
... offers improved ergonomics for today's exacting ... grippy finger rest and the large ... efficiency. Finnpipette Digitals also feature soft-touch ... (pat. pend.) and super blow-out for ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 100-1,000 microliter range....
... the #1 Pipettor for sub-microliter pipetting ... reliability. Continuously adjustable. Features lPLUS, a ... interchangeable ejector buttons to fit large ... pipet tip ejector with three different ...
Medicine Products: